Intracellular sensing of complement C3 activates cell autonomous immunity

Science

Volumn , Issue 6201, 2014, Pages 1134-

  Tam, Jerry C H ^a   Bidgood, Susanna R ^a   McEwan, William A ^a   James, Leo C ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; PROTEASOME; RIBONUCLEOPROTEIN; SS A ANTIGEN; SS-A ANTIGEN; TRANSCRIPTION FACTOR AP 1; VIRUS ANTIBODY; COMPLEMENT COMPONENT C4; RUPINTRIVIR;

ADENOVIRUS; ANIMAL; ARTICLE; BIOSYNTHESIS; DOG; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN ADENOVIRUS INFECTION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; SIGNAL TRANSDUCTION; ADENOVIRIDAE; ADENOVIRUS INFECTION; ANIMAL CELL; AUTOIMMUNITY; BACTERIUM DETECTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSOL; EMBRYO; FEMALE; HELA CELL LINE; HUMAN CELL; IMMUNOREACTIVITY; IMMUNOSURVEILLANCE; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; VIRUS DETECTION; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRUS INFECTIONS, HUMAN; ANIMALS; ANTIBODIES, VIRAL; COMPLEMENT C3; CYTOKINES; DOGS; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTORS; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; RIBONUCLEOPROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

BACTERIUM; CELLS AND CELL COMPONENTS; IMMUNE SYSTEM; INFECTIVITY; PATHOGEN; SIGNALING; VIRUS;

BACTERIA (MICROORGANISMS); ENTEROVIRUS; POLIOVIRUS; RHINOVIRUS;

EID: 84907212581     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1256070     Document Type: Article

References (57)

1. W. A. McEwan et al., Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat. Immunol. 14, 327-336 (2013). doi: 10.1038/ni.2548; pmid: 23455675.
2. R. E. Watkinson, J. C. H. Tam, M. J. Vaysburd, L. C. James, Simultaneous neutralization and innate immune detection of a replicating virus by TRIM21. J. Virol. 87, 7309-7313 (2013). doi: 10.1128/JVI.00647-13; pmid: 23596308
3. F. Hauler, D. L. Mallery, W. A. McEwan, S. R. Bidgood, L. C. James, AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization. Proc. Natl. Acad. Sci. U.S.A. 109, 19733-19738 (2012). doi: 10.1073/pnas.1210659109; pmid: 23091005
4. D. L. Mallery et al., Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc. Natl. Acad . Sci. U.S.A. 107, 19985-19990 (2010). doi: 10.1073/pnas.1014074107; pmid: 21045130
5. W. A. McEwan et al., Regulation of virus neutralization and the persistent fraction by TRIM21. J. Virol. 86, 8482-8491 (2012). doi: 10.1128/JVI.00728-12; pmid: 22647693
6. M. Vaysburd et al., Intracellular antibody receptor TRIM21 prevents fat al viral infection. Proc. Natl. Acad. Sci. U.S.A. 110, 12397-12401 (2013). doi: 10.1073/pnas.1301918110; pmid: 23840060
7. M. J. Walport, Complement. First of two parts. N. Engl. J. Med. 344, 1058-1066 (2001). pmid: 11287977
8. H. W. Favoreel, G. R. Van de Walle, H. J. Nauwynck, M. B. Pensaert, Virus complement evasion strategies. J. Gen. Virol. 84, 1- 15 (2003). doi: 10.1099/vir.0.18709-0; pmid: 12533696
9. D. M. Appledorn et al., Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors. Gene Ther. 15, 1606 -1617 (2008). doi: 10.1038/gt.2008.114; pmid: 18615115
10. R. S. Bonaparte et al., Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway. J. Virol. 82, 817 -827 (2008). doi: 10.1128/JVI.01847-07; pmid: 17959658
11. Z. Xu et al., Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat. Med. 19, 452-457 (2013). doi: 10.1038/nm.3107; pmid: 23524342
12. S. H. Rooijakkers, W. J. van Wamel, M. Ruyken, K. P. van Kessel, J. A. van Strijp, Anti-opsonic properties of staphylokinase. Microbes Infect. 7, 476 -484 (2005). doi: 10.1016/j. micinf.2004.12.014; pmid: 15792635
13. P. C. Reading et al., Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J. Immunol. 180, 3391 -3398 (2008). doi: 10.4049/jimmunol.180.5.3391; pmid: 18292565
14. D. C. Fritzinger, R. Bredehorst, C. W. Vogel, Molecular cloning and derived primary structure of cobra venom factor. Proc. Natl. Acad. Sci. U.S.A. 91, 12775 -12779 (1994). doi: 10.1073/pnas.91.26.12775; pmid: 7809120
15. P. F. Zipfel, C. Skerka, Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9, 729-740 (2009). pmid: 19730437
16. O. Meier, U. F. Greber, Adenovirus endocytosis. J. Gene Med. 6 (suppl. 1), S152-S163 (2004). doi: 10.1002/jgm.553; pmid: 14978758
17. J. O. Agola et al., A competitive nucleotide binding inhibitor: In vitro characterization of Rab7 GTPase inhibition. ACS Chem. Biol. 7, 1095-1108 (2012). doi: 10.1021/cb3001099; pmid: 22486388
18. G. Meiffren et al., Pathogen recognition by the cell surface receptor CD46 induces autophagy. Autophagy 6, 299- 300 (2010). doi: 10.4161/auto.6.2.11132; pmid: 20087059
19. T. Farkas, M. Daugaard, M. Jäättelä , Identification of small molecule inhibitors of phosphatidylinositol 3-kinase and autophagy. J. Biol. Chem. 286, 38904-38912 (2011). doi: 10.1074/jbc.M111.269134; pmid: 21930714
20. D. B. Stetson, R. Medzhitov, Type I interferons in host defense. Immunity 25, 373- 381 (2006). doi: 10.1016/j. immuni.2006.08.007; pmid: 16979569
21. J. J. Houle, E. M. Hoffmann, Evidence for restriction of the ability of complement to lyse homologous erythrocytes. J. Immunol. 133, 1444-1452 (1984).pmid: 6430999
22. C. L. Harr is, O. B. Spiller, B. P. Morgan, Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities. Immunology 100, 462 -470 (2000). doi: 10.1046/j.1365-2567.20 00.00066.x; pmid: 10929073
23. P. Seth, Mechanism of adenovirus-mediated endosome lysis: Role of the intact adenovirus capsid structure. Biochem. Biophys. Res. Commun. 205, 1318- 1324 (1994). doi: 10.1006/bbrc.1994.2809; pmid: 7802664
24. D. Schober, P. Kronenberger, E. Prchla, D. Blaas, R. Fuchs, Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms. J. Virol. 72, 1354-1364 (1998). pmid: 9445036
25. B. Brandenburg et al., Imaging poliovirus entry in live cells. PLOS Biol. 5, e183 (2007). doi: 10.1371/journal.pbio.0050183; pmid: 17622193
26. J. J. Seitsonen et al., Structural analysis of coxsackievirus A7 reveals conformational changes associated with uncoating. J. Virol. 86, 7207-7215 (2012). doi: 10.1128/JVI.06425-11; pmi d: 22514349
27. E. C. Smith, A. Popa, A. Chang, C. Masante, R. E. Dutch, Viral entry mechanisms: The increasing diversity of paramyxovirus entry. FEBS J. 276, 7217 -7227 (2009). doi: 10.1111/j.1742-4658.2009.07401.x; pmid: 19878307
28. C. L. Birmingham, J. H. Brumell, Autophagy recognizes intracellular Salmonella enterica serovar Typhimurium in damaged vacuoles. Autophagy 2, 156 -158 (2006). doi: 10.4161/auto.2825; pmid: 16874057
29. C. R. Beuzó n, S. P. Salcedo, D. W. Holden, Growth and killing of a Salmonella enterica serovar Typhimurium sifA mutant strain in the cytoso l of different host cell lines. Microbiology 148, 2705-2715 (2002). pmid: 12213917
30. R. S. Harris, J. F. Hultquist, D. T. Evans, The restriction factors of human immunodeficiency virus. J. Bio l. Chem. 287, 40875-40883 (2012). doi: 10.1074/jbc.R112.416925; pmid: 23043100
31. P. M. Barral, D. Sarkar, P. B. Fisher, V. R. Racaniello, RIG-I is cleaved during picornavirus infection. Virology 391, 171 -176 (2009). doi: 10.1016/j.virol.2009.06.045; pmid: 19628239
32. N. Blom, J. Hansen, S. Brunak, D. Blaas, Cleavage site analysis in picornaviral polyproteins: Discovering cellular targets by neural networks. Protein Sci. 5, 2203 -2216 (1996). doi: 10.1002/pro.5560051107; pmid: 8931139
33. A. K. Patick et al., In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob. Agents Chemother. 43, 2444-2450 (1999). pmid: 10508022
34. A. Gradi, Y. V. Svitkin, H. Imataka, N. Sonenberg, Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc. Natl. Acad. Sci. U.S.A. 95, 11089- 11094 (1998). doi: 10.1073/pnas.95.19.11089; pmid: 9736694
35. F. Hou et al., MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146, 448 -461 (2011). doi: 10.1016/j.cell.2011.06.041; pmid: 21782231
36. S. Paz et al., Ubiquitin-regulated recruitment of IkB kinase epsilon to the MAVS interferon signaling adapter. Mol. Cell. Biol. 29, 3401 -3412 (2009). doi: 10.1128/MCB.00880-08; pmid: 19380491
37. R.B. Seth,L. Sun,C.K. Ea,Z.J. Chen, Identification and characterizatio n of MAVS, a mitochondrial antiviral signaling protein that activates NF-kB and IRF 3, Cell, 122, 669-682, 2005, doi 10.1016/j.cell.2005.08.012, pmid: 16125763.
38. S. Liu et al., MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. eLife 2, e00785 (2013). doi: 10.7554/eLife.00785; pmid: 23951545
39. L. Sanz, M. T. Diaz-Meco, H. Nakano, J. Moscat, The atypical PKC-interacting protein p62 channels NF-kB activation by the IL-1-TRAF6 pathway. EMBO J. 19, 1576 -1586 (2000). doi: 10.1093/emboj/19.7.1576; pmid: 10747026
40. K. Clark, L. Plater, M. Peggie, P. Cohen, Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkB kinase epsilon: A distinct upstream kinase mediates Ser-172 phosphorylation and activation. J. Biol. Chem. 284, 14136- 14146 (2009). doi: 10.1074/jbc.M109.000414; pmid: 19307177
41. J. G. Gallagher, N. Khoobyarian, Adenovirus susceptibility to human interferon during one-step replication. Infect. Immun. 5, 905-908 (1972).pmid: 4344095
42. P. E. Came, T. W. Schafer, G. H. Silver, Sensitivity of rhinoviruses to human leukocyte and fibroblast interferons. J. Infect. Dis. 133 A136-A139 (1976). doi: 10.1093/infdis/133. Supplement-2.A136; pmid: 180194
43. T. Pertel et al., TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361- 365 (2011). doi: 10.1038/nature09976; pmid: 21512573
44. J. Bode et al., A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci. PLOS One 7, e50327 (2012). do i: 10.1371/journal.pone.0050327; pmid: 23189195
45. Y. Wang, X. Tong, J. Zhang, X. Ye, The complement C1qA enhances retinoic acid-inducible gene-I-mediated immune signalling. Immunology 136, 78- 85 (2012). doi: 10.1111/j.1365-2567.2012.03561.x; pmid: 22260551
46. L. S. Zalman et al., Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor. Antimicrob. Agents Chemother. 44, 1236 -1241 (2000). doi: 10.1128/AAC.44.5.1236-1241.2000; pmid: 10770757
47. M. Stremlau et al., The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427, 848 -853 (2004). doi: 10.1038/nature02343; pmid: 14985764
48. R. P. Galã o, A. Le Tortorec, S. Pickering, T. Kueck, S. J. Neil, Innate sensing of HIV-1 assembly by Tetherin induces NFkB-dependent proinflammatory responses. Cell Host Microbe 12, 633 -644 (2012). doi: 10.1016/j.chom.2012.1 0.007; pmid: 23159053
49. S. J. Neil, T. Zang, P. D. Bieniasz, Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425- 430 (2008). doi: 10.1038/nature06553; pmid: 18200009
50. C. B. Buck, C. D. Thompson, Production of papillomavirusbased gene transfer vectors. Curr. Protoc. Cell Biol. 26, 26.1 (2007).
51. U. Geigenmü ller, N. H. Ginzton, S. M. Matsui, Construction of a genome-length cDNA clone for human astrovirus serotype 1 and synthesis of infectious RNA transcripts. J. Virol. 71, 1713-1717 (1997).pmid: 8995706
52. C. Fuentes, A. Bosch, R. M. Pintó , S. Guix, Identification of human astrovirus genome-linked protein (VPg) essential for virus infectivity. J. Virol. 86, 10070-10078 (2012). doi: 10.1128/JVI.00797-12; pmid: 22787221
53. L. K. Hallak, D. Spillmann, P. L. Collins, M. E. Peeples, Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 74, 10508-10513 (2000). doi: 10.1 128/JVI.74.22.10508-10513.2000 pmid: 11044095
54. R. Feuer, I. Mena, R. Pagarigan, M. K. Slifka, J. L. Whitton, Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol. 76, 4430-4440 (2002). doi: 10.1128/JVI.76.9.4430-4440.2002 pmid: 11932410
55. C. W. Vogel, H. J. Mü ller-Eberhand, Cobra venom factor: Improved method for purification and biochemical c haracterization. J. Immunol. Methods 73, 203-220 (1984). doi: 10.1016/0022-1759(84)90045-0 pmid: 6491300
56. M. Costabile, Measuring the 50% haemolytic complement (CH50) activity of serum. J. Vis. Exp. 37, 1923 (2010). pmid: 20351687
57. P. Seth, M. Rosenfeld, J. Higginbotham, R. G. Crystal, Mechanism of enhancement of DNA expression consequent to cointernalization of a replication-deficient ad enovirus and unmodified plasmid DNA. J. Virol. 68, 933-940 (1994). pmid: 7507187